References
1. Jersoviene V, Gudleviciene Z, Rimiene J, Butkauskas D. Human Papillomavirus and Infertility. Medicina. 2019;55(7).
2. Souho T, Benlemlih M, Bennani B. Human papillomavirus infection and fertility alteration: a systematic review. PloS one. 2015;10(5):e0126936.
3. Xiong YQ, Chen YX, Cheng MJ, He WQ, Chen Q. The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis. Asian journal of andrology. 2018;20(5):493-7.
4. Lewitowicz P, Nasierowska-Guttmejer A, Rokita W, Adamczyk-Gruszka O, Gluszek S, Chrapek M, et al. HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion. Archives of Medical Science: AMS. 2020;16(1):87.
5. Kousha A MA, Maleki A, Najmi M, Dini M, Arjmandpour M. Package of Essential Non-communicable (PEN) disease interventions for primary health care in lran ”IRAPEN”. Tehran: Mojassameh; 2017. 56 p.
6. Bruni L B-RL, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé, S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Iran. 2017.
7. Perrin KK, Daley EM, Naoom SF, Packing-Ebuen JL, Rayko HL, McFarlane M, et al. Women’s reactions to HPV diagnosis: insights from in-depth interviews. Women & health. 2006;43(2):93-110.
8. Lin H, Jeng C-J, Wang L-R. Psychological responses of women infected with cervical human papillomavirus: a qualitative study in Taiwan. Taiwanese Journal of Obstetrics and Gynecology. 2011;50(2):154-8.
9. McRae J, Martin C, O’Leary J, Sharp L. ”If you can’t treat HPV, why test for it?” Women’s attitudes to the changing face of cervical cancer prevention: a focus group study. BMC women’s health. 2014;14:64.
10. Daley EM, Perrin KM, McDermott RJ, Vamos CA, Rayko HL, Packing-Ebuen JL, et al. The psychosocial burden of HPV: a mixed-method study of knowledge, attitudes and behaviors among HPV+ women. Journal of health psychology. 2010;15(2):279-90.
11. McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sexually transmitted infections. 2006;82(2):169-74.
12. Kosenko KA, Hurley RJ, Harvey JA. Sources of the uncertainty experienced by women with HPV. Qual Health Res. 2012;22(4):534-45.
13. Waller J, McCaffery K, Kitchener H, Nazroo J, Wardle J. Women’s experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study. Psychooncology. 2007;16(3):196-204.
14. Pourmohsen M, Simbar M, Nahidi F, Fakor F, Majd HA. Women’s Experiences of Infection With Human Papillomavirus in the Face of Disease Symptoms: A Qualitative Study.
15. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qualitative health research. 2005;15(9):1277-88.
16. Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. Analysing and presenting qualitative data. British dental journal. 2008;204(8):429.
17. Polit DF, Beck CT. Nursing research: Generating and assessing evidence for nursing practice: Lippincott Williams & Wilkins; 2008.
18. Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New directions for program evaluation. 1986;1986(30):73-84.
19. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International journal for quality in health care. 2007;19(6):349-57.
20. Depuydt CE, Donders G, Verstraete L, Vanden Broeck D, Beert J, Salembier G, et al. Time has come to include Human Papillomavirus (HPV) testing in sperm donor banks. Facts, views & vision in ObGyn. 2018;10(4):201-5.
21. Capra G, Schillaci R, Bosco L, Roccheri MC, Perino A, Ragusa MA. HPV infection in semen: results from a new molecular approach. 2019;147:e177.
22. Graziottin A, Serafini A. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions. J Sex Med. 2009;6(3):633-45.
23. McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sexually transmitted infections. 2006;82(2):169-74.
24. Lin H, Jeng CJ, Wang LR. Psychological responses of women infected with cervical human papillomavirus: a qualitative study in Taiwan. Taiwanese journal of obstetrics & gynecology. 2011;50(2):154-8.
25. Merckx M, Liesbeth W-VW, Arbyn M, Meys J, Weyers S, Temmerman M, et al. Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies. Eur J Cancer Prev. 2013;22(3):277-85.
26. Nøhr B, Kjaer SK, Soylu L, Jensen A. High-risk human papillomavirus infection in female and subsequent risk of infertility: a population-based cohort study. Fertility and sterility. 2019;111(6):1236-42.
27. Zacharis K, Messini CI. Human Papilloma Virus (HPV) and Fertilization: A Mini Review. 2018;54(4).
28. Ambühl LM, Baandrup U, Dybkær K, Blaakær J, Uldbjerg N, Sørensen S. Human Papillomavirus Infection as a Possible Cause of Spontaneous Abortion and Spontaneous Preterm Delivery. Infectious diseases in obstetrics and gynecology. 2016;2016:3086036.
29. Perino A, Giovannelli L, Schillaci R, Ruvolo G, Fiorentino FP, Alimondi P, et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. Fertility and sterility. 2011;95(5):1845-8.
30. Spandorfer SD, Bongiovanni AM, Fasioulotis S, Rosenwaks Z, Ledger WJ, Witkin SS. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertility and sterility. 2006;86(3):765-7.
31. who.int. Human papilloma virus vaccines and infertility
WHO Weekly Epidemiological Record of 24 January 2020; 2019 [cited 2020 July]. Extract from GACVS meeting of 4-5 December 2019]. Available from: https://www.who.int/vaccine_safety/committee/topics/hpv/Dec_2019/en/.
32. Kyrgiou M, Mitra A, Arbyn M, Paraskevaidi M, Athanasiou A, Martin-Hirsch PP, et al. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia. The Cochrane database of systematic reviews. 2015;2015(9):Cd008478.
33. Daley EM, Marhefka SL, Buhi ER, Vamos CA, Hernandez ND, Giuliano AR. Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sexually transmitted diseases. 2010;37(10):644-52.
34. Sun L, Herkanaidu PK, Mohur P, Ramudoo J. Effect of pregnancy on HPV infection and on its mode of management. Med J Obstet Gynecol. 2017;5(2):1099.
35. Bonde U, Joergensen JS, Lamont RF, Mogensen O. Is HPV vaccination in pregnancy safe? Human vaccines & immunotherapeutics. 2016;12(8):1960-4.
36. Tan J, Xiong YQ, He Q, Liu YM, Wang W, Chen M, et al. Peri-conceptional or pregnancy exposure of HPV vaccination and the risk of spontaneous abortion: a systematic review and meta-analysis. 2019;19(1):302.
37. Nohr B, Kjaer SK, Soylu L, Jensen A. High-risk human papillomavirus infection in female and subsequent risk of infertility: a population-based cohort study. Fertility and sterility. 2019;111(6):1236-42.
38. Andía D, Mozo de Rosales F, Villasante A, Rivero B, Díez J, Pérez C. Pregnancy outcome in patients treated with cervical conization for cervical intraepithelial neoplasia. International Journal of Gynecology & Obstetrics. 2011;112(3):225-8.
39. Ehsanipoor RM, Jolley JA, Goldshore MA, Szymanski LM, Haydon ML, Gaffaney CL, et al. The relationship between previous treatment for cervical dysplasia and preterm delivery in twin gestations. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2014;27(8):821-4.
40. Tseng CJ, Liang CC, Soong YK, Pao CC. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstetrics and gynecology. 1998;91(1):92-6.
41. Savoca S, Nardo LG, Rosano TF, D’Agosta S, Nardo F. CO(2) laser vaporization as primary therapy for human papillomavirus lesions. A prospective observational study. Acta obstetricia et gynecologica Scandinavica. 2001;80(12):1121-4.
42. Skoczyński M, Goździcka-Józefiak A, Kwaśniewska A. Co-occurrence of human papillomavirus (HPV) in newborns and their parents. BMC infectious diseases. 2019;19(1):930.
43. Pradhan SR, Mahata S, Ghosh D, Sahoo PK, Sarkar S, Pal R, et al. Human Papilloma Virus Infections in Pregnant Women and Its Impact on Pregnancy Outcomes: Possible Mechanism of Self-Clearance. Human Papillomavirus: IntechOpen; 2020.
44. Volpato LK, Siqueira IR, Nunes RD, Piovezan AP. Association between Hormonal Contraception and Injuries Induced by Human Papillomavirus in the Uterine Cervix. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2018;40(4):196-202.